Tylenol, a branch of Johnson & Johnson McNeil, have recalled at least five of its over-the-counter pain medications.
The recall was due to a review of cleaning procedures of equipment that was either not properly documented or done insufficiently. Johnson & Johnson stressed that, for all the recalled medications, no adverse events have been reported and that consumers who bought them can continue to use them. Although the latest Johnson & Johnson recall does not directly impact consumers, it may cause many to question the reliability and quality of the companyâ€™s products.
The Tylenol recall was done with consultation from the Food and Drug Administration (FD) as a precautionary measure The recall contains six varieties of diphenhydramine-containing Benadryl medications, 10 types of Sudafed (pseudoephedrine), and 24-count packages of Sinutab (acetaminophen and phenylephrine) coated tablets within 37 different types of McNeil’s Tylenol brand of acetaminophen-based product.
Johnson & Johnson had more than a dozen recalls during 2010, including one for Rolaids Softchews on December 9; Tylenol Cold Liquid products on November 24, Childrenâ€™s Benadryl Allergy Fastmelt Tablets on November 15, Junior Strength Motrin on November 15, Rolaids Extra Strength Softchews on November 15, Tylenol 8 Hour on October 18, and various Tylenol products plus Benadryl Allergy Ultratab Tablets and Motrin IB products on July 8.
Adding to Johnson & Johnson list of problems, the FDA announced this week that acetaminophen, the active ingredient in Tylenol, is being overused. Too much, the FDA says, can lead to liver damage. They now recommend that tablets contain no more 325 mg, while some products previously contained as much as 750 mg per tablet. That recommendation will probably lead to a decrease in Tylenol use.